Weitz Formulations Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2018.
2018 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Weitz Formulations Private Limited

Weitz Formulations Private Limited, a active private limited company, was established on 13 March 2018 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999DL2018PTC330826. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Suhail Ahmad Kath (Director), Zaid Showkat (Director), Hilal Ahmad Zargar (Director). It is based at C/O Shazia Mir R/Oh.No.234-K Third Floor Gali No. 7 Zakir Nagar Jamia Nagar, New Delhi, Delhi, 110025.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999DL2018PTC330826

  • Registration Number

    330826

  • Incorporation Date

    13 March 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 2 Months
Company report

Weitz Formulations Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Weitz Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Weitz Formulations Private Limited?
Current Directors
Name Designation Appointment Date Status
Suhail Ahmad Kath Director 13 Mar 2018 Current
Zaid Showkat Director 21 Jan 2020 Current
Hilal Ahmad Zargar Director 13 Mar 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Weitz Formulations.

Enhance accessibility to Weitz Formulations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Weitz Formulations revenue growth over time
Weitz Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Weitz Formulations?

Unlock access to Weitz Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Weitz Formulations?

Unlock and access historical data on people associated with Weitz Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Weitz Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Weitz Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Weitz Formulations
Recent Activity within the Organization
  • Director Appointment

    Zaid Showkat was appointed as a Director was appointed as a Director on 21 Jan 2020 & has been associated with this company since 6 years 4 months . was recorded as a recent event.

  • Director Appointment

    Progress on Suhail Ahmad Kath was appointed as a Director was appointed as a Director on 13 Mar 2018 & has been associated with this company since 8 years 2 months . was documented.

  • Director Appointment

    Hilal Ahmad Zargar was appointed as a Director was appointed as a Director on 13 Mar 2018 & has been associated with this company since 8 years 2 months . was recorded as a recent event.

  • Company Incorporation

    The activity Weitz Formulations Private Limited was registered on 13 Mar 2018 with Roc Delhi I & aged 8 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Weitz Formulations Private Limited?

The CIN of Weitz Formulations Private Limited is U74999DL2018PTC330826.

Where is Weitz Formulations Private Limited headquartered?

Weitz Formulations Private Limited is headquartered at C/O Shazia Mir R/Oh.No.234-K Third Floor Gali No. 7 Zakir Nagar Jamia Nagar, New Delhi, Delhi, 110025.

When was Weitz Formulations Private Limited incorporated?

Weitz Formulations Private Limited was incorporated on 13 March 2018.

Who are the current directors of Weitz Formulations Private Limited?

The current directors of Weitz Formulations Private Limited are

What is the primary industry of Weitz Formulations Private Limited?

The primary industry of Weitz Formulations Private Limited is Pharma.

Is Weitz Formulations Private Limited a listed company?

Weitz Formulations Private Limited is unlisted.

What is the capital structure of Weitz Formulations Private Limited?

The authorized capital of Weitz Formulations Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available